By Stephanie PappasThe medical device company Diode Therapeutics is set to introduce its latest version of a 3D printing printer into the market.
The company announced today that it will offer the printer in the next few months to a number of its patients.
Diode will be the first company to offer a 3d printer to patients at the Australian International Hospital, which is currently a part of a consortium of hospitals.
In its announcement, Diode said it is “committed to bringing the best in technology to the most challenging conditions of our time.”
The printer is designed to be used for research, development and commercialization.
“Diode is excited to offer this new technology to a wide range of patients with chronic illnesses and diseases,” Diode CEO Mark Korn said in a statement.
Dr. Andrew Schmitt, a professor of dermatology at the University of Queensland and a specialist in skin, skin cancers and dermatological surgery, said the new technology could help patients with melanoma, lung and pancreatic cancer.
Schmitt said the technology can be used to create customized models that would be more accurate than the traditional method.
“It’s a very good idea,” Schmitt said.
Korn said that while 3D printers were the future, the current technology was not very good.
He said the company is working on a solution to address this.
If successful, DiODE hopes the printer will be a new standard for printing medical materials.
This could be useful for patients in hospitals and clinics that are using 3D scanning, for example.
But some people are concerned that the technology could be dangerous.
Dianne Stiles, a clinical professor at the Mayo Clinic in Minnesota, said that if the printer were to be injected into the bloodstream of a patient, the device could be used in a way that could make it harder for the patient to survive.
That’s because the printer would be injected directly into the patient’s bloodstream, she said.
“You can’t imagine how potentially it could cause problems with the patient in the long run,” Stiles said.
Diode’s announcement comes as the U.S. Food and Drug Administration is reviewing the safety of the injection technique used by Diode.
Earlier this month, the FDA issued a new warning that it would be “more cautious” about the injection of 3D-printed needles.
The agency said it was reviewing the device, which has been tested in clinical trials, and could recommend against using it in humans.